Business Context and Reporting Period
Company: Globus Medical, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: May 7, 2026
Reporting Period: Three months ended March 31, 2026
This filing serves as a notification that the Company issued a press release on May 7, 2026, detailing its sales and operating results for the first quarter of fiscal year 2026. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for the actual figures. Consequently, the following metrics are not available in this document:
- Revenue
- Profit (Net Income/Operating Income)
- Cash Flow
- Margins
- Debt and Liquidity
Note: The filing text does not provide a clear value for any financial metric.
Material Changes
The filing text does not disclose specific material changes, year-over-year comparisons, or variance analysis. It only confirms that results for the period ended March 31, 2026, have been reported in a separate press release.
Guidance, Outlook, and Risks
No guidance, outlook, management commentary, risks, contingencies, or unusual items are detailed in the provided text. The document explicitly states that the information in Item 2.02 and the attached exhibit is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 7, 2026) for actual revenue, earnings, and margin figures.
- Verify the specific year-over-year growth rates and segment performance in the press release.
- Check for any updated forward-looking guidance or capital allocation plans in the press release.
- Confirm the status of the "furnished" vs. "filed" designation regarding liability under Section 18 of the Exchange Act.